Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
European Journal of Biochemistry
|
March 15, 1997
Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells
B Loir, B Bouchard, R Morandini, et al.
Melanoma Research
|
September 14, 2000
Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro
S J Hedley, A Murray, K Sisley, et al.
The British Journal of Dermatology
|
March 24, 2000
Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin
P Eves, C Layton, S Hedley, et al.
Pigment Cell Research
|
October 21, 2000
Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitro
S M Neil, P Eves, B Richardson, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines
J W Haycock, S J Rowe, S Cartledge, et al.
FEBS Letters
|
August 2, 1993
TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture
V del Marmol, S Ito, I Jackson, et al.
Contrast Media & Molecular Imaging
|
February 14, 2014
Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study
Q Godechal, L Mignion, O Karroum, et al.
The British Journal of Dermatology
|
May 15, 1998
alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines
S J Hedley, D J Gawkrodger, A P Weetman, et al.
Melanoma Research
|
April 1, 1996
E-cadherin expression in human melanoma
E H Danen, T J de Vries, R Morandini, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
S Testa, O Paoletti, C Legnani, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
European Journal of Biochemistry
|
March 15, 1997
Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells
B Loir, B Bouchard, R Morandini, et al.
Melanoma Research
|
September 14, 2000
Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro
S J Hedley, A Murray, K Sisley, et al.
The British Journal of Dermatology
|
March 24, 2000
Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin
P Eves, C Layton, S Hedley, et al.
Pigment Cell Research
|
October 21, 2000
Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitro
S M Neil, P Eves, B Richardson, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines
J W Haycock, S J Rowe, S Cartledge, et al.
FEBS Letters
|
August 2, 1993
TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture
V del Marmol, S Ito, I Jackson, et al.
Contrast Media & Molecular Imaging
|
February 14, 2014
Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high-field (11.7 T) MRI and EPR study
Q Godechal, L Mignion, O Karroum, et al.
The British Journal of Dermatology
|
May 15, 1998
alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines
S J Hedley, D J Gawkrodger, A P Weetman, et al.
Melanoma Research
|
April 1, 1996
E-cadherin expression in human melanoma
E H Danen, T J de Vries, R Morandini, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 14, 2018
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
S Testa, O Paoletti, C Legnani, et al.
Page
of 4